DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Omni Rancho Las Palmas Resort & Spa

2018 年 03 月 19 日 1:00 下午 - 2018 年 03 月 21 日 4:00 下午

41000 Bob Hope Drive, Rancho Mirage, CA 92270

Medical Affairs and Scientific Communications Forum

Medical Communication, MSL, and Medical Writing.

Session 7 Track 3: Policy Updates: The Evolution of Customer-Facing Medical Roles

Session Chair(s)

Kathryn  Bucci, PharmD

Kathryn Bucci, PharmD

Medical Governance Lead

Pfizer, Inc., United States

Ed  Cunningham, PharmD

Ed Cunningham, PharmD

Sunovion Pharmaceuticals, Inc., United States

Recent court rulings and environmental trends are shaping what pharma can communicate about their products. The current FDA rules pose challenges and the need for clarification as companies work to interpret these rules. As the demand for medical information continues to increase, this session will discuss how the interpretation and application of these rules is expected to further evolve the role of customer-facing medical teams.

Learning Objective : At the conclusion of this session, participants should be able to:
  • Prepare an overview of recent court rulings regarding manufacturers’ ability to communicate
  • Describe the current challenges in FDA rules and how they influence pharma companies
  • Explain how companies are interpreting and applying the rules to customer-facing medical roles
  • Describe what the industry can do to advance capabilities and move field-based medical roles forward

Speaker(s)

Michelle  Drozd

Speaker

Michelle Drozd

Pharmaceutical Research and Manufacturers of America (PhRMA), United States

Deputy Vice President, Policy & Research

Michael S. Labson, JD

Speaker

Michael S. Labson, JD

Covington & Burling LLP, United States

Partner

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。